S
Silvia Taccogna
Researcher at Sapienza University of Rome
Publications - 26
Citations - 1836
Silvia Taccogna is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Thyroid & Thyroid nodules. The author has an hindex of 11, co-authored 19 publications receiving 1742 citations.
Papers
More filters
Journal ArticleDOI
Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.
Enrico Papini,Rinaldo Guglielmi,Antonio Bianchini,Anna Crescenzi,Silvia Taccogna,Francesco Nardi,Claudio Panunzi,R. Rinaldi,Vincenzo Toscano,Claudio Maurizio Pacella +9 more
TL;DR: The aim of the study was to correlate the sonographic and color-Doppler findings with the results of US-guided fine needle aspiration biopsy and of pathologic staging of resected carcinomas to establish the relative importance of US features as risk factors of malignancy and a cost-effective management of nonpalpable thyroid nodules.
Journal ArticleDOI
Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique.
Naim Nasrollah,Pierpaolo Trimboli,Leo Guidobaldi,Davide Domenico Cicciarella Modica,Claudio Ventura,Giovanni Ramacciato,Silvia Taccogna,Francesco Romanelli,Stefano Valabrega,Anna Crescenzi +9 more
TL;DR: Thin core biopsy should help to discern the nature of thyroid lesions cytologically classified as indeterminate, and it should be used as a complementary test in thyroid nodule assessment.
Journal ArticleDOI
Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis.
Claudio Maurizio Pacella,Giancarlo Bizzarri,Giampiero Francica,Antonio Bianchini,Stefano De Nuntis,Sara Pacella,Anna Crescenzi,Silvia Taccogna,Giuseppe Forlini,Z. Rossi,John Osborn,Roberto Stasi +11 more
TL;DR: PLA is a highly effective treatment in patients with hepatocellular carcinoma with a tumor size of 4.0 cm or smaller and the number of treatments required to obtain tumor necrosis is low.
Journal Article
Human Malignant Thyroid Tumors Displayed Reduced Levels of Transforming Growth Factor β Receptor Type II Messenger RNA and Protein
Davide Lazzereschi,Annalisa Ranieri,Gabriella Mincione,Silvia Taccogna,Francesco Nardi,Giulia Colletta +5 more
TL;DR: Data indicate that loss of expression of TbetaRII can contribute to thyroid cancer progression, inducing cancer cells to escape the growth-inhibitory effect of TGF-beta.
Journal ArticleDOI
Predictive Value of Malignancy of Thyroid Nodule Ultrasound Classification Systems: A Prospective Study.
Agnese Persichetti,Enrico Di Stasio,Rinaldo Guglielmi,Giancarlo Bizzarri,Silvia Taccogna,Irene Misischi,Filomena Graziano,L. Petrucci,Antonio Bianchini,Enrico Papini +9 more
TL;DR: In this paper, the diagnostic accuracy of US classification systems and their reliability for indication to fine-needle aspiration (FNA) was evaluated for 987 thyroid nodules consecutively referred for FNA.